LIVER CANCER DISEASE TREATMENT WITH NANOMEDICINE: AN OVERVIEW
ABSTRACT:
Liver cancer is a very dangerous disease accordingly 80000 people around the world. The liver is a vital organ of great significance that is responsible for the detoxification of exogenous and internal threats such xenobiotics, viral infections, and chronic alcoholism as well as the maintenance of metabolic processes. Due to the paucity of therapeutic management alternatives besides liver resection and transplantation, liver disorders, in particular hepatitis B virus infections, liver cirrhosis, and hepatocellular carcinoma, continue to constitute a serious health problem globally. The third most common cancer in the world and the sixth most common cancer overall is hepatocellular carcinoma (HCC). Nanomedicine has emerged as a promising approach for the treatment of liver cancer. Liver cancer, a severe and deadly disease, requires innovative therapies to improve patient outcomes. Nanoparticles, specifically designed to target cancer cells, offer several advantages in liver cancer treatment. These nanoparticles can be loaded with anticancer drugs, allowing for targeted delivery and enhanced therapeutic efficacy. Additionally, they can overcome biological barriers and penetrate deep into tumor tissues, maximizing drug accumulation at the site of the tumor. Furthermore, nanomedicine enables the combination of multiple therapeutic agents, such as chemotherapy drugs and immunotherapeutic agents, in a single nanoparticle formulation. This synergistic approach holds great potential in overcoming drug resistance and improving treatment outcomes for liver cancer patients. With further research and development, nanomedicine has the potential to revolutionize the treatment of liver cancer and provide new hope for patients.
Keywords: Hepatocellular carcinoma, Nanomedicine, Nanomaterial, Targeted Drug Delivery, Abdominal swelling.
No comments:
Post a Comment